MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Artificial Cells Nanomedicine and Biotechnology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

34 results · 1 filter active ·
Results by year
20122022
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
34 works in the cohort · of 4,299,418page 1 of 1

Labels cover 0 of 34 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 34 of 34 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology
Thomas Ming Swi Chang
2019· review· en· Artificial Cells Nanomedicine and Biotechnology· Engineering
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · metaepi_narrow+research_integrity
55
citations
afffundunlabeled
Lowering of elevated tissue PCO<sub>2</sub>in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxidant properties
Yuzhu Bian, Wei Gao, Thomas Ming Swi Chang
2013· article· en· Artificial Cells Nanomedicine and Biotechnology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
15
citations
afffundunlabeled
Design of a novel gut bacterial adhesion model for probiotic applications
Laetitia Rodes, Michael Coussa-Charley, Daniel-Costin Marinescu, Arghya Paul, Marc Fakhoury, Sana Abbasi +3 more
2012· article· en· Artificial Cells Nanomedicine and Biotechnology· Agricultural and Biological Sciences
distilled prediction:candidate · noneconsensus · none
12
citations

How this was built: Screen · Findings · About